share_log

Navigating 4 Analyst Ratings For Bio-Techne

Benzinga ·  Apr 18 12:01

In the preceding three months, 4 analysts have released ratings for Bio-Techne (NASDAQ:TECH), presenting a wide array of perspectives from bullish to bearish.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings11200
Last 30D10000
1M Ago00000
2M Ago00000
3M Ago01200

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $77.25, along with a high estimate of $87.00 and a low estimate of $65.00. Experiencing a 11.54% decline, the current average is now lower than the previous average price target of $87.33.

price target chart

Understanding Analyst Ratings: A Comprehensive Breakdown

A comprehensive examination of how financial experts...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment